Efficacy of CRISPR-Cas9 gene editing for targeting KRAS mutations in pancreatic cancer: a systematic review.

Saved in:
Bibliographic Details
Title: Efficacy of CRISPR-Cas9 gene editing for targeting KRAS mutations in pancreatic cancer: a systematic review.
Authors: Hashim HT; College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq. hashim.h.t.h@gmail.com., Alhatemi AQM; Al-Nassiryah Teaching Hospital, Nassiryah, Thi Qar, Iraq., Fatima T; King Edward Medical University Lahore, Lahore, Pakistan., Haque T; Comilla Medical College, Comilla, Bangladesh., Sulaiman FA; Al-Nassiryah Teaching Hospital, Nassiryah, Thi Qar, Iraq., Ganim M; National Center for Gastroenterology and Liver Diseases, Khartoum, Sudan. mohammedganim2001@gmail.com., Abdullah MA; Al-Numaan Teaching Hospital, Baghdad, Iraq., Kadhum RA; Anesthesia Techniques Department, College of Health and Medical Techniques, Al-Mustaqbal University, Babylon, 51001, Iraq., Al-Obaidi AD; College of Medicine, MBChB, University of Baghdad, Baghdad, Iraq., Al-Obaidi A; Department of Hematology/Oncology, University of Missouri-Kansas City, 2411 Holmes St, Kansas City, MO, 64108, USA.
Source: Discover oncology [Discov Oncol] 2025 Apr 23; Vol. 16 (1), pp. 596. Date of Electronic Publication: 2025 Apr 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2730-6011
DOI:10.1007/s12672-025-02231-w